BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21441258)

  • 21. Detection of feigned ADHD in college students.
    Sollman MJ; Ranseen JD; Berry DT
    Psychol Assess; 2010 Jun; 22(2):325-35. PubMed ID: 20528060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship of malingering test failure to self-reported symptoms and neuropsychological findings in adults referred for ADHD evaluation.
    Suhr J; Hammers D; Dobbins-Buckland K; Zimak E; Hughes C
    Arch Clin Neuropsychol; 2008 Sep; 23(5):521-30. PubMed ID: 18562158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The utility of the MMPI-2 malingering discriminant function index in the detection of malingering: a study of criminal defendants.
    Toomey JA; Kucharski LT; Duncan S
    Assessment; 2009 Mar; 16(1):115-21. PubMed ID: 18607009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incremental validity of the MMPI-2-RF over-reporting scales and RBS in assessing the veracity of memory complaints.
    Gervais RO; Ben-Porath YS; Wygant DB; Sellbom M
    Arch Clin Neuropsychol; 2010 Jun; 25(4):274-84. PubMed ID: 20335183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of the Conners' Adult ADHD Rating Scale validity scales in identifying simulated attention-deficit hyperactivity disorder and random responding.
    Walls BD; Wallace ER; Brothers SL; Berry DTR
    Psychol Assess; 2017 Dec; 29(12):1437-1446. PubMed ID: 29227125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship of noncredible performance to continuous performance test scores in adults referred for attention-deficit/hyperactivity disorder evaluation.
    Suhr JA; Sullivan BK; Rodriguez JL
    Arch Clin Neuropsychol; 2011 Feb; 26(1):1-7. PubMed ID: 21159792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Henry-Heilbronner Index: a 15-item empirically derived MMPI-2 subscale for identifying probable malingering in personal injury litigants and disability claimants.
    Henry GK; Heilbronner RL; Mittenberg W; Enders C
    Clin Neuropsychol; 2006 Dec; 20(4):786-97. PubMed ID: 16980262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of overreporting on MMPI-2-RF substantive scale score validity.
    Burchett DL; Ben-Porath YS
    Assessment; 2010 Dec; 17(4):497-516. PubMed ID: 20739584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A known-groups evaluation of the response bias scale in a neuropsychological setting.
    Sullivan KA; Elliott CD; Lange RT; Anderson DS
    Appl Neuropsychol Adult; 2013; 20(1):20-32. PubMed ID: 23373681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing attention-deficit/hyperactivity disorder in adults: focus on rating scales.
    Murphy KR; Adler LA
    J Clin Psychiatry; 2004; 65 Suppl 3():12-7. PubMed ID: 15046530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The predictive capacity of the MMPI-2 and PAI validity scales and indexes to detect coached and uncoached feigning.
    Bagby RM; Nicholson RA; Bacchiochi JR; Ryder AG; Bury AS
    J Pers Assess; 2002 Feb; 78(1):69-86. PubMed ID: 11936213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative analysis of MMPI-2 malingering detection models among inmates.
    Steffan JS; Morgan RD; Lee J; Sellbom M
    Assessment; 2010 Jun; 17(2):185-96. PubMed ID: 20124427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptom and performance validity with veterans assessed for attention-deficit/hyperactivity disorder (ADHD).
    Shura RD; Denning JH; Miskey HM; Rowland JA
    Psychol Assess; 2017 Dec; 29(12):1458-1465. PubMed ID: 29227127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing symptoms of attention deficit hyperactivity disorder in children and adults: which is more valid?
    Faraone SV; Biederman J; Feighner JA; Monuteaux MC
    J Consult Clin Psychol; 2000 Oct; 68(5):830-42. PubMed ID: 11068969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MMPI-2 restructured form over-reporting scales in first-episode psychosis.
    Purdon SE; Purser SM; Goddard KM
    Clin Neuropsychol; 2011 Jul; 25(5):829-42. PubMed ID: 21756212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of the post-concussive symptom questionnaire.
    Van Dyke SA; Axelrod BN; Schutte C
    Arch Clin Neuropsychol; 2010 Nov; 25(7):634-9. PubMed ID: 20710017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does the disorder matter? Investigating a moderating effect on coached noncredible overreporting using the MMPI-2 and PAI.
    Veltri CO; Williams JE
    Assessment; 2013 Apr; 20(2):199-209. PubMed ID: 23118265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examination of the new MMPI-2 Response Bias Scale (Gervais): relationship with MMPI-2 validity scales.
    Nelson NW; Sweet JJ; Heilbronner RL
    J Clin Exp Neuropsychol; 2007 Jan; 29(1):67-72. PubMed ID: 17162723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of simulating borderline personality disorder on the MMPI-2: a costs-benefits model employing base rates.
    Sivec HJ; Hilsenroth MJ; Lynn SJ
    J Pers Assess; 1995 Apr; 64(2):295-311. PubMed ID: 7722855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying students faking ADHD: Preliminary findings and strategies for detection.
    Harrison AG; Edwards MJ; Parker KC
    Arch Clin Neuropsychol; 2007 Jun; 22(5):577-88. PubMed ID: 17507198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.